Isabelle Stoeckert
Bayer (Germany)(DE)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Meta-analysis and systematic reviews, Statistical Methods in Clinical Trials, Pharmaceutical industry and healthcare, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Balancing benefit and risk of medicines: a systematic review and classification of available methodologies(2014)118 cited
- → How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action(2023)22 cited
- → Benefit–risk assessment in a post‐market setting: a case study integrating real‐life experience into benefit–risk methodology(2014)21 cited
- → Digital Tools—Regulatory Considerations for Application in Clinical Trials(2023)13 cited
- → What Next for the Science of Patient Preference? Interoperability, Standardization, and Transferability(2025)2 cited
- → P6 EMA/EUnetHTA Qualification of the IMI PREFER Patient Preference Framework and Points to Consider for Method Selection: Key Experiences, Outcomes, Value and Implications(2022)1 cited